Division of Abdominal Cancer, Department of Medical Oncology, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Cancer Metastasis Rev. 2024 Sep;43(3):941-957. doi: 10.1007/s10555-024-10178-7. Epub 2024 Mar 4.
Metastasis remains the principal trigger for relapse and mortality across diverse cancer types. Circulating tumor cells (CTCs), which originate from the primary tumor or its metastatic sites, traverse the vascular system, serving as precursors in cancer recurrence and metastasis. Nevertheless, before CTCs can establish themselves in the distant parenchyma, they must overcome significant challenges present within the circulatory system, including hydrodynamic shear stress (HSS), oxidative damage, anoikis, and immune surveillance. Recently, there has been a growing body of compelling evidence suggesting that a specific subset of CTCs can persist within the bloodstream, but the precise mechanisms of their survival remain largely elusive. This review aims to present an outline of the survival challenges encountered by CTCs and to summarize the recent advancements in understanding the underlying survival mechanisms, suggesting their implications for cancer treatment.
转移仍然是各种癌症类型复发和死亡的主要诱因。循环肿瘤细胞(CTCs)来源于原发性肿瘤或其转移部位,它们穿过血管系统,成为癌症复发和转移的前体。然而,在 CTCs 能够在远处实质中定居之前,它们必须克服循环系统中存在的重大挑战,包括流体切应力(HSS)、氧化损伤、失巢凋亡和免疫监视。最近,越来越多的令人信服的证据表明,特定亚群的 CTCs 可以在血液中持续存在,但它们的生存确切机制在很大程度上仍难以捉摸。本综述旨在概述 CTCs 所遇到的生存挑战,并总结对其潜在生存机制的最新理解,提示它们对癌症治疗的影响。
Cancer Metastasis Rev. 2024-9
Biomed Res Int. 2018-11-1
Cancer Cell. 2017-9-11
Int J Mol Sci. 2020-7-17
Cell Rep. 2022-8-30
Mil Med Res. 2025-2-11
Mol Biomed. 2025-2-8
J Cancer Res Clin Oncol. 2023-11
Signal Transduct Target Ther. 2023-3-7
Free Radic Biol Med. 2022-11-20
Front Oncol. 2022-3-30